ID: h-SDA-2026-04-26-gap-debate-20260426-011
Hypothesis
Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Blood as an Early Indicator of BBB Tight Junction Proteolysis
Elevated MMP-9/TIMP-1 ratio reflects net proteolytic activity against the BBB, causing degradation of tight junction proteins (claudin-5, occludin, ZO-1) and increased permeability.
neurodegeneration
EvidencePending (0%)📖 8 cit🗣 1 debates✓ 8 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
Elevated MMP-9/TIMP-1 ratio reflects net proteolytic activity against the BBB, causing degradation of tight junction proteins (claudin-5, occludin, ZO-1) and increased permeability. This imbalance precedes measurable cognitive decline and represents a blood-accessible biomarker. The hypothesis has the strongest evidence base with the additional advantage of having clinically plausible interventions available for repurposing (anti-MMP-9 antibodies such as anrukinzumab and GS-5745). Primary limitation is the lack of specificity for neurodegeneration versus systemic inflammation.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD A["Elevated MMP-9/TIMP-1 ratio"] B["Increased net proteolytic activity"] C["Degradation of tight junction proteins"] D["BBB tight junction proteolysis"] E["Increased BBB permeability"] F["Blood-accessible biomarker detection"] G["Early cognitive decline"] H["Anrukinzumab (anti-MMP-9 antibody)"] I["GS-5745 (anti-MMP-9 antibody)"] J["Inhibition of MMP-9 activity"] A -->|"causes"| B B -->|"targets"| C C -->|"cleaves"| D D -->|"results in"| E E -->|"enables"| F E -->|"precedes"| G H -->|"blocks"| J I -->|"blocks"| J J -->|"reduces"| A A -->|"elevated in"| F
⚖️ Evidence
⚖️ Evidence Matrix8 supports3 contradicts
Supports
Tissue inhibitor metalloproteinase-1 and clinical outcomes after acute ischemic stroke.
Supports
Serum matrix metallopeptidase-9 levels in infantile epileptic spasms syndrome of unknown etiology.
Supports
An evaluation of matrix metalloproteinase-9 (Mmp-9) and tissue inhibitor metalloproteinase-1 (Timp-1) Serum levels and the Mmp-9/Timp-1 Ratio in Covid-19 patients.
Supports
May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?
Supports
Plasma MMP-9/TIMP-1 ratio serves as a novel potential biomarker in Alzheimer's disease.
Supports
Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.
Supports
Comparison of MMP-2 and TIMP-2 expressions in yak testes at different ages.
Supports
Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm - comparison with and without bicuspid aortic valve: a meta-analysis.
Contradicts
MMP-9 levels showed no independent association with dementia risk after cardiovascular adjustment
Contradicts
Evidence base primarily from stroke models not directly translatable to chronic neurodegeneration
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — MMP-9
No curated PDB or AlphaFold mapping for MMP-9 yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for MMP-9 (Matrix Metallopeptidase 9) / TIMP-1 ratio from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for MMP-9 (Matrix Metallopeptidase 9).
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↘
Falling
7d Momentum
▼ 1.1%
Volatility
Medium
0.0420
Events (7d)
3
Price History
▼16.6%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| If MMP-9/TIMP-1 ratio specifically reflects brain-derived MMP-9 activity rather than systemic neutrophils, then ratio will correlate with CSF MMP-9 activity and with MRI measures of BBB leakage but no | Paired plasma/CSF samples (n≥80) show plasma MMP-9/TIMP-1 ratio correlates with CSF MMP-9 activity (r>0.55), with DCE-MRI Ktrans (r>0.45), but not with blood ne | — no observation — | pending | 0.71 |
| If MMP-9/TIMP-1 ratio in peripheral blood identifies early BBB tight junction degradation before clinical symptoms, then elevated MMP-9/TIMP-1 ratio will predict conversion from cognitively normal to | In CN subjects followed for 3 years (n≥150), those with baseline MMP-9/TIMP-1 ratio in top tertile show 3-4x higher MCI conversion rate, elevated CSF t-tau/p-ta | — no observation — | pending | 0.75 |
🔮 Falsifiable Predictions (2)
pendingconf —
If MMP-9/TIMP-1 ratio in peripheral blood identifies early BBB tight junction degradation before clinical symptoms, then elevated MMP-9/TIMP-1 ratio will predict conversion from cognitively normal to MCI, correlating with CSF biomarkers of neurodegeneration but not with systemic inflammatory conditi
Predicted outcome: In CN subjects followed for 3 years (n≥150), those with baseline MMP-9/TIMP-1 ratio in top tertile show 3-4x higher MCI conversion rate, elevated CSF
Falsification: MMP-9/TIMP-1 ratio does not predict MCI conversion; elevated ratio occurs equally in non-converters and converters, and shows no correlation with CSF neurodegeneration markers, indicating peripheral M
pendingconf —
If MMP-9/TIMP-1 ratio specifically reflects brain-derived MMP-9 activity rather than systemic neutrophils, then ratio will correlate with CSF MMP-9 activity and with MRI measures of BBB leakage but not with peripheral neutrophil counts or plasma CRP.
Predicted outcome: Paired plasma/CSF samples (n≥80) show plasma MMP-9/TIMP-1 ratio correlates with CSF MMP-9 activity (r>0.55), with DCE-MRI Ktrans (r>0.45), but not wit
Falsification: Plasma MMP-9/TIMP-1 ratio correlates equally with peripheral neutrophil counts and systemic CRP; CSF MMP-9 shows no correlation with plasma ratio or MRI BBB measures, indicating plasma ratio reflects
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.